These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 16044416)

  • 1. In vitro evaluation of platelet reactivity toward annuloplasty devices treated with heparin coating: studies under flow conditions.
    Tonda R; Galán AM; Pino M; Hernández MR; Ayats C; Pomar JL; Ordinas A; Escolar G
    J Biomed Mater Res A; 2005 Oct; 75(1):192-8. PubMed ID: 16044416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does the additional use of heparin-coated extracorporeal circuits (ECC) optimize the effect of modified ultrafiltration (MUF) in pediatric perfusion?
    Harig F; Meier C; Hakami L; Strasser R; Bretzger J; Münch F; Vestweber-Wilmes E; Singer H; Weyand M; Cesnjevar R
    Thorac Cardiovasc Surg; 2006 Apr; 54(3):168-72. PubMed ID: 16639677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biocompatibility of heparin-coated cardiopulmonary bypass circuits in coronary patients with left ventricular dysfunction is superior to PMEA-coated circuits.
    Kutay V; Noyan T; Ozcan S; Melek Y; Ekim H; Yakut C
    J Card Surg; 2006; 21(6):572-7. PubMed ID: 17073955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical study of biocompatibility between open and closed heparin-coated cardiopulmonary bypass circuits.
    Tanaka H; Oshiyama T; Narisawa T; Mori T; Masuda M; Kishi D; Kitou T; Miyazima S
    J Artif Organs; 2003; 6(4):245-52. PubMed ID: 14691666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and biomaterial evaluation of hyaluronan-based heparin-bonded extracorporeal circuits with reduced versus full systemic anticoagulation in reoperation for coronary revascularization.
    Gunaydin S; Farsak B; McCusker K; Vijay V; Sari T; Onur MA; Gurpinar A; Zorlutuna Y
    J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):135-42. PubMed ID: 19377380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of heparin-coated circuits on hemodynamics during and after cardiopulmonary bypass.
    de Vroege R; Huybregts R; van Oeveren W; van Klarenbosch J; Linley G; Mutlu J; Jansen E; Hack E; Eijsman L; Wildevuur C
    Artif Organs; 2005 Jun; 29(6):490-7. PubMed ID: 15926987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of heparin-bonded circuits in cardiopulmonary bypass improves clinical outcome.
    Svenmarker S; Häggmark S; Jansson E; Lindholm R; Appelblad M; Sandström E; Aberg T
    Scand Cardiovasc J; 2002 Aug; 36(4):241-6. PubMed ID: 12201973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new poly-2-methoxyethylacrylate-coated cardiopulmonary bypass circuit possesses superior platelet preservation and inflammatory suppression efficacy.
    Ikuta T; Fujii H; Shibata T; Hattori K; Hirai H; Kumano H; Suehiro S
    Ann Thorac Surg; 2004 May; 77(5):1678-83. PubMed ID: 15111165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin-bonded surfaces in extracorporeal membrane oxygenation for cardiac support.
    von Segesser LK
    Ann Thorac Surg; 1996 Jan; 61(1):330-5; discussion 340-1. PubMed ID: 8561600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of blood components exposed to coated arterial filters in extracorporeal circuits.
    Hussaini BE; Treanor PR; Healey NA; Tilahun D; Srey R; Lu XG; Khuri SF; Thatte HS
    Perfusion; 2009 Sep; 24(5):317-23. PubMed ID: 19965951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression changes in leukocytes during cardiopulmonary bypass are dependent on circuit coating.
    Seeburger J; Hoffmann J; Wendel HP; Ziemer G; Aebert H
    Circulation; 2005 Aug; 112(9 Suppl):I224-8. PubMed ID: 16159821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective analysis of outcome data with regards to the use of Phisio®-, Bioline®- or Softline®-coated cardiopulmonary bypass circuits in cardiac surgery.
    Reser D; Seifert B; Klein M; Dreizler T; Hasenclever P; Falk V; Starck C
    Perfusion; 2012 Nov; 27(6):530-4. PubMed ID: 22864552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect of heparin-coated circuits on the platelets during cardiopulmonary bypass.
    Zhang K; Hu Z; Yang Y; Huang R; Fan H; Sun Z
    J Huazhong Univ Sci Technolog Med Sci; 2003; 23(4):403-6. PubMed ID: 15015647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The AN69 ST haemodialysis membrane under conditions of two different extracorporeal circuit rinse protocols a comparison of thrombogenicity parameters.
    Richtrova P; Opatrny K; Vit L; Sefrna F; Perlik R
    Nephrol Dial Transplant; 2007 Oct; 22(10):2978-84. PubMed ID: 17597089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of complement inhibition and heparin coating on artificial surface-induced leukocyte and platelet activation.
    Lappegård KT; Fung M; Bergseth G; Riesenfeld J; Lambris JD; Videm V; Mollnes TE
    Ann Thorac Surg; 2004 Mar; 77(3):932-41. PubMed ID: 14992902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of a new heparin-coated dense membrane lung with nonheparin-coated dense membrane lung for prolonged extracorporeal lung assist in goats.
    Ichinose K; Okamoto T; Tanimoto H; Yoshitake A; Tashiro M; Sakanashi Y; Kuwana K; Tahara K; Kamiya M; Terasaki H
    Artif Organs; 2004 Nov; 28(11):993-1001. PubMed ID: 15504115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombogenicity is not reduced when heparin and phospholipid bonded circuits are used in a rabbit model of extracorporeal circulation.
    Meinhardt JP; Annich GM; Miskulin J; Kawai T; Ashton BA; Bartlett RH
    ASAIO J; 2003; 49(4):395-400. PubMed ID: 12918580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin-bonded cardiopulmonary bypass circuits reduce the rate of red blood cell transfusion during elective coronary artery bypass surgery.
    Kreisler KR; Vance RA; Cruzzavala J; Mahnken JD
    J Cardiothorac Vasc Anesth; 2005 Oct; 19(5):608-11. PubMed ID: 16202894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trillium coating of cardiopulmonary bypass circuits improves biocompatibility.
    Tevaearai HT; Mueller XM; Seigneul I; Burki M; Horisberger J; Stumpe F; Von Segesser LK
    Int J Artif Organs; 1999 Sep; 22(9):629-34. PubMed ID: 10532432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biocompatibility of extracorporeal blood treatment. Selection of haemostatic parameters.
    Lindhout T
    Nephrol Dial Transplant; 1994; 9 Suppl 2():83-9. PubMed ID: 8065621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.